Nicole M. Scharenborg

Author

Also Known As

N M Scharenborg, N. M. Scharenborg, N. Scharenborg, N.M Scharenborg, N.M. Scharenborg, Nicole M Scharenborg, Nicole M. Scharenborg, Nicole Scharenborg, Scharenborg, N.M.

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center University of Twente Radboud Institute for Molecular Life Sciences Amsterdam UMC Location University of Amsterdam

About

Nicole M. Scharenborg is an author at Radboud University Nijmegen specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.2K
2	Cell Biology	8	8	946
3	Engineering	5	5	302
4	Biomedical Engineering	4	4	216
5	Biomolecular Engineering	1	1	34

Nicole M. Scharenborg

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. I. Jolanda M. de Vries, Daniëlle J. E. B. Krooshoop, Nicole M. Scharenborg, PubMed Adaptive Immune SystemImmunologyDermatologyImmune SystemImmunotherapy	2003	479
Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients. I. Jolanda M. de Vries, W. Joost Lesterhuis, Nicole M. Scharenborg, PubMed	2003	329
Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients Joannes F.M. Jacobs, Cornelis J.A. Punt, W. Joost Lesterhuis, Clinical Cancer Research	2010	234
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells Gerty Schreibelt, Kalijn F. Bol, Harm Westdorp, Clinical Cancer Research	2015	231
Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients W. Joost Lesterhuis, I. Jolanda M. de Vries, Gerty Schreibelt, Clinical Cancer Research	2011	187
Immunomonitoring Tumor-Specific T Cells in Delayed-Type Hypersensitivity Skin Biopsies After Dendritic Cell Vaccination Correlates With Clinical Outcome I. Jolanda M. de Vries, Monique R. Bernsen, W. Joost Lesterhuis, Journal of Clinical Oncology	2005	184
Phenotypical and Functional Characterization of Clinical Grade Dendritic Cells I. Jolanda M. de Vries, Andreas A. O. Eggert, Nicole M. Scharenborg, Journal of Immunotherapy	2002	159
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration A.C.I. Boullart, Erik H.J.G. Aarntzen, Pauline Verdijk, Cancer Immunology Immunotherapy	2008	150
Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests W. Joost Lesterhuis, I. Jolanda M. de Vries, Danita H. Schuurhuis, Annals of Oncology VaccinationCancer ImmunosurveillanceDth Skin TestsT-regulatory CellImmunology	2006	99
Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients. W. Joost Lesterhuis, I. Jolanda M. de Vries, Gerty Schreibelt, PubMed	2010	95

Page 1